CD2AP is associated with end-stage renal disease in patients with type 1 diabetes

Mervi E. Hyvönen, Pekka Ihalmo, Niina Sandholm, Monica Stavarachi, Carol Forsblom, Amy Jayne McKnight, Maria Lajer, Anna Maestroni, Gareth Lewis, Lise Tarnow, Silvia Maestroni, Gianpaolo Zerbini, Hans Henrik Parving, Alexander P. Maxwell, Per Henrik Groop, Sanna Lehtonen

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

CD2-associated protein (CD2AP) is essential for podocyte function. CD2AP mutations have been found in patients with focal segmental glomerulosclerosis, a disease histologically resembling diabetic nephropathy and often progressing to end-stage renal disease (ESRD). We hypothesised that variations in the CD2AP gene may contribute to susceptibility to glomerular injury in diabetes and investigated if single-nucleotide polymorphisms (SNPs) in CD2AP are associated with diabetic nephropathy in patients with type 1 diabetes. The discovery cohort consisted of 2,251 Finnish patients with type 1 diabetes. SNPs were selected from the HapMap database to cover the CD2AP gene. The associations between genotyped SNPs and diabetic nephropathy or ESRD were analysed with the chi-squared test and logistic regression. Three SNPs were selected for replication in cohorts from Denmark, Italy, the United Kingdom and Ireland. None of the 15 successfully genotyped SNPs were associated with diabetic nephropathy when compared to patients with normal albumin excretion rate. However, when genotype frequencies in patients with ESRD were compared with all other patients, two CD2AP SNPs, rs9369717 and rs9349417, were found to be associated with ESRD. The meta-analysis of the original and two additional European cohorts resulted in significant p values

Original languageEnglish
Pages (from-to)887-897
Number of pages11
JournalActa Diabetologica
Volume50
Issue number6
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Type 1 Diabetes Mellitus
Chronic Kidney Failure
Single Nucleotide Polymorphism
Diabetic Nephropathies
HapMap Project
Focal Segmental Glomerulosclerosis
Podocytes
Denmark
Ireland
Italy
Genes
Meta-Analysis
CD2-associated protein
Albumins
Logistic Models
Genotype
Databases
Mutation
Wounds and Injuries

Keywords

  • Diabetic nephropathy
  • End-stage renal disease
  • Genetics
  • Type 1 diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Hyvönen, M. E., Ihalmo, P., Sandholm, N., Stavarachi, M., Forsblom, C., McKnight, A. J., ... Lehtonen, S. (2013). CD2AP is associated with end-stage renal disease in patients with type 1 diabetes. Acta Diabetologica, 50(6), 887-897. https://doi.org/10.1007/s00592-013-0475-9

CD2AP is associated with end-stage renal disease in patients with type 1 diabetes. / Hyvönen, Mervi E.; Ihalmo, Pekka; Sandholm, Niina; Stavarachi, Monica; Forsblom, Carol; McKnight, Amy Jayne; Lajer, Maria; Maestroni, Anna; Lewis, Gareth; Tarnow, Lise; Maestroni, Silvia; Zerbini, Gianpaolo; Parving, Hans Henrik; Maxwell, Alexander P.; Groop, Per Henrik; Lehtonen, Sanna.

In: Acta Diabetologica, Vol. 50, No. 6, 12.2013, p. 887-897.

Research output: Contribution to journalArticle

Hyvönen, ME, Ihalmo, P, Sandholm, N, Stavarachi, M, Forsblom, C, McKnight, AJ, Lajer, M, Maestroni, A, Lewis, G, Tarnow, L, Maestroni, S, Zerbini, G, Parving, HH, Maxwell, AP, Groop, PH & Lehtonen, S 2013, 'CD2AP is associated with end-stage renal disease in patients with type 1 diabetes', Acta Diabetologica, vol. 50, no. 6, pp. 887-897. https://doi.org/10.1007/s00592-013-0475-9
Hyvönen ME, Ihalmo P, Sandholm N, Stavarachi M, Forsblom C, McKnight AJ et al. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes. Acta Diabetologica. 2013 Dec;50(6):887-897. https://doi.org/10.1007/s00592-013-0475-9
Hyvönen, Mervi E. ; Ihalmo, Pekka ; Sandholm, Niina ; Stavarachi, Monica ; Forsblom, Carol ; McKnight, Amy Jayne ; Lajer, Maria ; Maestroni, Anna ; Lewis, Gareth ; Tarnow, Lise ; Maestroni, Silvia ; Zerbini, Gianpaolo ; Parving, Hans Henrik ; Maxwell, Alexander P. ; Groop, Per Henrik ; Lehtonen, Sanna. / CD2AP is associated with end-stage renal disease in patients with type 1 diabetes. In: Acta Diabetologica. 2013 ; Vol. 50, No. 6. pp. 887-897.
@article{c7dc5b1d204446a28cad854dfd5f110e,
title = "CD2AP is associated with end-stage renal disease in patients with type 1 diabetes",
abstract = "CD2-associated protein (CD2AP) is essential for podocyte function. CD2AP mutations have been found in patients with focal segmental glomerulosclerosis, a disease histologically resembling diabetic nephropathy and often progressing to end-stage renal disease (ESRD). We hypothesised that variations in the CD2AP gene may contribute to susceptibility to glomerular injury in diabetes and investigated if single-nucleotide polymorphisms (SNPs) in CD2AP are associated with diabetic nephropathy in patients with type 1 diabetes. The discovery cohort consisted of 2,251 Finnish patients with type 1 diabetes. SNPs were selected from the HapMap database to cover the CD2AP gene. The associations between genotyped SNPs and diabetic nephropathy or ESRD were analysed with the chi-squared test and logistic regression. Three SNPs were selected for replication in cohorts from Denmark, Italy, the United Kingdom and Ireland. None of the 15 successfully genotyped SNPs were associated with diabetic nephropathy when compared to patients with normal albumin excretion rate. However, when genotype frequencies in patients with ESRD were compared with all other patients, two CD2AP SNPs, rs9369717 and rs9349417, were found to be associated with ESRD. The meta-analysis of the original and two additional European cohorts resulted in significant p values",
keywords = "Diabetic nephropathy, End-stage renal disease, Genetics, Type 1 diabetes",
author = "Hyv{\"o}nen, {Mervi E.} and Pekka Ihalmo and Niina Sandholm and Monica Stavarachi and Carol Forsblom and McKnight, {Amy Jayne} and Maria Lajer and Anna Maestroni and Gareth Lewis and Lise Tarnow and Silvia Maestroni and Gianpaolo Zerbini and Parving, {Hans Henrik} and Maxwell, {Alexander P.} and Groop, {Per Henrik} and Sanna Lehtonen",
year = "2013",
month = "12",
doi = "10.1007/s00592-013-0475-9",
language = "English",
volume = "50",
pages = "887--897",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer-Verlag Italia s.r.l.",
number = "6",

}

TY - JOUR

T1 - CD2AP is associated with end-stage renal disease in patients with type 1 diabetes

AU - Hyvönen, Mervi E.

AU - Ihalmo, Pekka

AU - Sandholm, Niina

AU - Stavarachi, Monica

AU - Forsblom, Carol

AU - McKnight, Amy Jayne

AU - Lajer, Maria

AU - Maestroni, Anna

AU - Lewis, Gareth

AU - Tarnow, Lise

AU - Maestroni, Silvia

AU - Zerbini, Gianpaolo

AU - Parving, Hans Henrik

AU - Maxwell, Alexander P.

AU - Groop, Per Henrik

AU - Lehtonen, Sanna

PY - 2013/12

Y1 - 2013/12

N2 - CD2-associated protein (CD2AP) is essential for podocyte function. CD2AP mutations have been found in patients with focal segmental glomerulosclerosis, a disease histologically resembling diabetic nephropathy and often progressing to end-stage renal disease (ESRD). We hypothesised that variations in the CD2AP gene may contribute to susceptibility to glomerular injury in diabetes and investigated if single-nucleotide polymorphisms (SNPs) in CD2AP are associated with diabetic nephropathy in patients with type 1 diabetes. The discovery cohort consisted of 2,251 Finnish patients with type 1 diabetes. SNPs were selected from the HapMap database to cover the CD2AP gene. The associations between genotyped SNPs and diabetic nephropathy or ESRD were analysed with the chi-squared test and logistic regression. Three SNPs were selected for replication in cohorts from Denmark, Italy, the United Kingdom and Ireland. None of the 15 successfully genotyped SNPs were associated with diabetic nephropathy when compared to patients with normal albumin excretion rate. However, when genotype frequencies in patients with ESRD were compared with all other patients, two CD2AP SNPs, rs9369717 and rs9349417, were found to be associated with ESRD. The meta-analysis of the original and two additional European cohorts resulted in significant p values

AB - CD2-associated protein (CD2AP) is essential for podocyte function. CD2AP mutations have been found in patients with focal segmental glomerulosclerosis, a disease histologically resembling diabetic nephropathy and often progressing to end-stage renal disease (ESRD). We hypothesised that variations in the CD2AP gene may contribute to susceptibility to glomerular injury in diabetes and investigated if single-nucleotide polymorphisms (SNPs) in CD2AP are associated with diabetic nephropathy in patients with type 1 diabetes. The discovery cohort consisted of 2,251 Finnish patients with type 1 diabetes. SNPs were selected from the HapMap database to cover the CD2AP gene. The associations between genotyped SNPs and diabetic nephropathy or ESRD were analysed with the chi-squared test and logistic regression. Three SNPs were selected for replication in cohorts from Denmark, Italy, the United Kingdom and Ireland. None of the 15 successfully genotyped SNPs were associated with diabetic nephropathy when compared to patients with normal albumin excretion rate. However, when genotype frequencies in patients with ESRD were compared with all other patients, two CD2AP SNPs, rs9369717 and rs9349417, were found to be associated with ESRD. The meta-analysis of the original and two additional European cohorts resulted in significant p values

KW - Diabetic nephropathy

KW - End-stage renal disease

KW - Genetics

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84890560124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890560124&partnerID=8YFLogxK

U2 - 10.1007/s00592-013-0475-9

DO - 10.1007/s00592-013-0475-9

M3 - Article

C2 - 23681557

AN - SCOPUS:84890560124

VL - 50

SP - 887

EP - 897

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

IS - 6

ER -